The life sciences industry has recently been rocked by dramatic changes in how healthcare is provided, how drugs are developed and researched, the technologies available that enable compani
On Friday, 3rd February, pharmaphorum travelled to Casa Angelini, Angelini Ventures HQ in Rome – the corporate venture vessel of Angelini Industries – for the inaugural Demo Day
The use of artificial intelligence (AI) in the biopharma industry has the potential to revolutionise drug discovery and development, as well as improve patient care.
Editor-in-chief Jonah Comstock caught up with Alexandre LeVert, chairman, CEO, and co-founder of Osivax, on the sidelines of JP Morgan in San Francisco at the beginning of January of this year.&nbs
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
